3 | SEC Filings Hub

Filing metadata

Accession number: 0000950170-24-130246
Form type: Form 3
Filer: Akari Therapeutics Plc
CIK: CIK 1541157
Filed: Nov 22, 2024
Reporting period: Nov 14, 2024
Description: Initial ownership

Documents

0000950170-24-130246-index.htm

Complete submission

0000950170-24-130246.txt

directory listing

Filed by

Akari Therapeutics Plc